Evaluation of a novel paclitaxel-coated intravascular balloon
- 11 views
- 30 Aug 2018
The Charing Cross Symposium (CX) first took place in 1978 at Charing Cross Hospital, Hammersmith, London, and has gone on to become the longest running vascular and endovascular symposium in Europe as well as one of the largest such meetings in the world. London (UK) has been the host city of CX ever since. Until 1998, the symposium was held at Charing Cross Hospital, and between 1999 and 2012 at Imperial College. In 2013, it moved to National Hall, Olympia, and in 2014 to Olympia Grand. The first CX had 100 attendees. In 2018, the Charing Cross Symposium – Controversies Update had more than 4,000 participants, from 86 countries, making it a leading global event. The Charing Cross Symposium raises vascular and endovascular controversies so that a world-class faculty challenges the available evidence in order to reach a consensus after discussion with an expert audience. This forms a three-year cycle. Challenges will be discussed in 2019.
Flexible Tigris stent used with IVUS
What will be the impact of the new EU medical device regulations on innovation?
Screening for abdominal aortic aneurysm is cost-effective and a policy on...
Drug Coated Balloons for SFA: Always or in Selective Lesions
Update on Chronic Limb Ischemia: Case Based